Related references
Note: Only part of the references are listed.Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy
Akihiro Asai et al.
PLOS ONE (2007)
Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
Guy L. Odom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Nitric oxide release combined with nonsteroidal anti inflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy
Silvia Brunelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice
Yongping Yue et al.
MOLECULAR THERAPY (2006)
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Paul Gregorevic et al.
NATURE MEDICINE (2006)
Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium
M Wehling-Henricks et al.
HUMAN MOLECULAR GENETICS (2005)
Novel mutations in three patients with LGMD2C with phenotypic differences
S Vermeer et al.
PEDIATRIC NEUROLOGY (2004)
Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice
P Gregorevic et al.
MUSCLE & NERVE (2004)
Structural abnormalities at neuromuscular synapses lacking multiple syntrophin isoforms
ME Adams et al.
JOURNAL OF NEUROSCIENCE (2004)
Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide
JP Eu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Vasomodulation by skeletal muscle-derived nitric oxide requires α-syntrophin-mediated sarcolemmal localization of neuronal nitric oxide synthase
GD Thomas et al.
CIRCULATION RESEARCH (2003)
Loss of sarcolemma nNOS in sarcoglycan-deficient muscle
RH Crosbie et al.
FASEB JOURNAL (2002)
Functional characteristics of dystrophic skeletal muscle: insights from animal models
JF Watchko et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria
T Mongini et al.
NEUROPEDIATRICS (2002)
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
M Wehling et al.
JOURNAL OF CELL BIOLOGY (2001)
A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy
S Matecki et al.
NEUROMUSCULAR DISORDERS (2001)
Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury
C Dellorusso et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2001)
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy
M Sander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)